The joint venture will link Crest Cellulose, a privately owned India-based excipient manufacturer’s production capabilities with Roquette’s experience in the pharmaceutical excipients market.
Carole Petitjean, head of corporate communications, Roquette, told us, “Our customers will benefit from an enlarged range of cellulose-based excipients thanks to the Crest Cellulose portfolio.”
She added that the agreement will “further advance our position and capability to serve our customers and the market with superior solutions and an expanded choice.”
Roquette previously acquired India-based Blanver Pharmaceutical’s excipients division in 2017, and stated that it is committed to increasing its footprint and proximity to its customers in India and Asia.
The purchase, according to Peitijean, will also work to “strengthen” the company’s position these regions, which the company regards as ‘key’ due to the areas being emerging, fast-growing markets.
According to Roquette, India has a large and fast-growing pharmaceutical sector that was estimated to be worth $33bn (€29bn) in 2017 and was growing at 10% per year at the beginning of 2018.
Financial details of the purchase have not been disclosed.